133 related articles for article (PubMed ID: 27390311)
21. [The expression of Ras protein in human middle ear cholesteatoma].
Xu Y; Jin K; Dong W
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
[TBL] [Abstract][Full Text] [Related]
22. [The expressions and correlations of RAR-beta receptors and galectin-8 in human middle ear cholesteatoma].
Peng L; Cui Y; Liu A
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 18(7):427-9. PubMed ID: 15499989
[TBL] [Abstract][Full Text] [Related]
23. [Expression and significance of PTEN, P-ERK and P-AKT in the middle ear cholesteatoma].
Liu D; Ma X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Feb; 28(4):238-42, 245. PubMed ID: 24800539
[TBL] [Abstract][Full Text] [Related]
24. Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium.
Chae SW; Song JJ; Suh HK; Jung HH; Lim HH; Hwang SJ
Laryngoscope; 2000 Nov; 110(11):1898-901. PubMed ID: 11081606
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor expression in middle ear cholesteatoma.
Chi HP; Ho KY; Chai CY; Ta CF; Wang LF; Lee KW; Kuo WR; Wu SC; Tsai SM
Kaohsiung J Med Sci; 2004 Jan; 20(1):6-11. PubMed ID: 15481560
[TBL] [Abstract][Full Text] [Related]
26. Corneodesmosin gene ablation induces lethal skin-barrier disruption and hair-follicle degeneration related to desmosome dysfunction.
Leclerc EA; Huchenq A; Mattiuzzo NR; Metzger D; Chambon P; Ghyselinck NB; Serre G; Jonca N; Guerrin M
J Cell Sci; 2009 Aug; 122(Pt 15):2699-709. PubMed ID: 19596793
[TBL] [Abstract][Full Text] [Related]
27. Differential gene expression in cholesteatoma by DNA chip analysis.
Macias JD; Gerkin RD; Locke D; Macias MP
Laryngoscope; 2013 Oct; 123 Suppl S5():S1-21. PubMed ID: 23670528
[TBL] [Abstract][Full Text] [Related]
28. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7.
Caubet C; Jonca N; Brattsand M; Guerrin M; Bernard D; Schmidt R; Egelrud T; Simon M; Serre G
J Invest Dermatol; 2004 May; 122(5):1235-44. PubMed ID: 15140227
[TBL] [Abstract][Full Text] [Related]
29. Expression of RANKL and OPG in middle ear cholesteatoma tissue.
Jeong JH; Park CW; Tae K; Lee SH; Shin DH; Kim KR; Park YW
Laryngoscope; 2006 Jul; 116(7):1180-4. PubMed ID: 16826057
[TBL] [Abstract][Full Text] [Related]
30. Possible participation of acidic pH in bone resorption in middle ear cholesteatoma.
Nguyen KH; Suzuki H; Ohbuchi T; Wakasugi T; Koizumi H; Hashida K; Baba R; Morimoto H; Doi Y
Laryngoscope; 2014 Jan; 124(1):245-50. PubMed ID: 24122656
[TBL] [Abstract][Full Text] [Related]
31. LEKTI domains D6, D7 and D8+9 serve as substrates for transglutaminase 1: implications for targeted therapy of Netherton syndrome.
Wiegmann H; Valentin F; Tarinski T; Liebau E; Loser K; Traupe H; Oji V
Br J Dermatol; 2019 Nov; 181(5):999-1008. PubMed ID: 30801672
[TBL] [Abstract][Full Text] [Related]
32. [Study of long non-coding RNA HOTAIR expression in middle ear cholesteatoma].
Li Q; Wang HQ; Chen YQ; Xiong S; Zeng L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(4):250-253. PubMed ID: 29871236
[No Abstract] [Full Text] [Related]
33. Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages.
Komatsu N; Takata M; Otsuki N; Toyama T; Ohka R; Takehara K; Saijoh K
J Invest Dermatol; 2003 Sep; 121(3):542-9. PubMed ID: 12925213
[TBL] [Abstract][Full Text] [Related]
34. EGFR expression in acquired middle ear cholesteatoma in children and adults.
Alves AL; Pereira CS; Carvalho Mde F; Fregnani JH; Ribeiro FQ
Eur J Pediatr; 2012 Feb; 171(2):307-10. PubMed ID: 21800041
[TBL] [Abstract][Full Text] [Related]
35. Refined Immunochemical Characterization in Healthy Dog Skin of the Epidermal Cornification Proteins, Filaggrin, and Corneodesmosin.
Pin D; Pendaries V; Keita Alassane S; Froment C; Amalric N; Cadiergues MC; Serre G; Haftek M; Vidémont E; Simon M
J Histochem Cytochem; 2019 Feb; 67(2):85-97. PubMed ID: 30199656
[TBL] [Abstract][Full Text] [Related]
36. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
[TBL] [Abstract][Full Text] [Related]
37. Cholesteatoma growth and proliferation: relevance with serpin B3.
Ho KY; Huang HH; Hung KF; Chen JC; Chai CY; Chen WT; Tsai SM; Chien CY; Wang HM; Wu YJ
Laryngoscope; 2012 Dec; 122(12):2818-23. PubMed ID: 23239141
[TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.
Welkoborsky HJ; Jacob RS; Hinni ML
Eur Arch Otorhinolaryngol; 2007 Aug; 264(8):841-8. PubMed ID: 17541620
[TBL] [Abstract][Full Text] [Related]
39. Cell proliferation and apoptosis in human middle ear cholesteatoma.
Kojima H; Tanaka Y; Tanaka T; Miyazaki H; Shiwa M; Kamide Y; Moriyama H
Arch Otolaryngol Head Neck Surg; 1998 Mar; 124(3):261-4. PubMed ID: 9525508
[TBL] [Abstract][Full Text] [Related]
40. KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome.
Furio L; Pampalakis G; Michael IP; Nagy A; Sotiropoulou G; Hovnanian A
PLoS Genet; 2015 Sep; 11(9):e1005389. PubMed ID: 26390218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
